Case number 1:23-cv-01080
Azurity Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 14, 2024 | 40 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of Dismissal)(mdb) (Entered: 05/14/2024) (0) |
| May 14, 2024 | 39 | SO ORDERED re 38 Stipulation of Dismissal without prejudice ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 5/14/2024. (dlw) (Entered: 05/14/2024) (2) |
| May 13, 2024 | 38 | STIPULATION of Dismissal without prejudice by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc. (Silver, Daniel) Modified on 5/14/2024 (dlw). (Entered: 05/13/2024) (2) |
| May 6, 2024 | 37 | NOTICE of Appearance by Maliheh Zare on behalf of Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited (Zare, Maliheh) (Entered: 05/06/2024) (2) |
| May 1, 2024 | 36 | NOTICE requesting Clerk to remove Alexandra Joyce as co-counsel. Reason for request: No Longer Counsel of Record. (Joyce, Alexandra) (Entered: 05/01/2024) (2) |
| Apr 29, 2024 | N/A | SO ORDERED re 35 STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to May 13, 2024. ORDERED by Judge Maryellen Noreika on 4/29/2024. (dlw) (Entered: 04/29/2024) (0) |
| Apr 29, 2024 | 35 | STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to May 13, 2024 - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) (Entered: 04/29/2024) (2) |
| Apr 12, 2024 | N/A | SO ORDERED re 34 STIPULATION TO EXTEND TIME to submit a proposed protective order to April 29, 2024. ORDERED by Judge Maryellen Noreika on 4/12/2024. (dlw) (Entered: 04/12/2024) (0) |
| Apr 12, 2024 | 34 | STIPULATION TO EXTEND TIME submit a proposed protective order to April 29, 2024 - filed by Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 04/12/2024) (2) |
| Apr 1, 2024 | N/A | SO ORDERED re 33 Joint STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 15, 2024. ORDERED by Judge Maryellen Noreika on 4/1/2024. (dlw) (Entered: 04/01/2024) (0) |
| Mar 29, 2024 | 33 | Joint STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 15, 2024 - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) (Entered: 03/29/2024) (2) |
| Mar 28, 2024 | 32 | NOTICE OF SERVICE of Defendant Teva Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 03/28/2024) (2) |
| Mar 28, 2024 | 31 | NOTICE OF SERVICE of Plaintiffs' Initial Paragraph 3 Disclosures Regarding Custodians and Non-Custodial Data Sources filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) (Entered: 03/28/2024) (2) |
| Mar 26, 2024 | 30 | NOTICE OF SERVICE of Defendant Teva Pharmaceuticals, Inc.'s Initial Disclosures filed by Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 03/26/2024) (2) |
| Mar 26, 2024 | 29 | NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) (Entered: 03/26/2024) (2) |
| Mar 21, 2024 | 28 | NOTICE OF SERVICE of Plaintiffs' Initial Paragraph 4 Disclosures Identifying Teva's Accused Products and Plaintiff's Asserted Patents filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) (Entered: 03/21/2024) (2) |
| Mar 21, 2024 | 27 | SCHEDULING ORDER: Joinder of Parties due by 10/10/2024. Amended Pleadings due by 10/10/2024. Fact Discovery completed by 12/6/2024. Opening Expert Reports due by 2/6/2025. Rebuttal Expert Reports due by 3/13/2025. Reply Expert Reports due by 4/8/2025. Expert Discovery due by 5/9/2025. Claim Construction Opening Brief served by 9/16/2024. Claim Construction Answering Brief served by 10/17/2024. Claim Construction Reply Brief served by 11/8/2024. Claim Construction Surreply Brief served by 11/21/2024. Joint Claim Construction Brief filed by 12/19/2024. A Markman Hearing is set for 1/10/2025 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 7/14/2025 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 7/21/2025 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 3/21/2024. (dlw) (Entered: 03/21/2024) (13) |
| Mar 5, 2024 | 26 | PROPOSED ORDER // Scheduling Order by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) Modified on 3/5/2024 (dlw). (Entered: 03/05/2024) (13) |
| Feb 15, 2024 | N/A | Pro Hac Vice Attorney Sarah E. Spencer for Arbor Pharmaceuticals, LLC and Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00833-MN, 1:23-cv-01080-MN(mpb) (Entered: 02/15/2024) (0) |
| Feb 12, 2024 | N/A | Pro Hac Vice Attorneys Chad J. Peterman, Christopher P. Hill, and Michael F. Werno for Arbor Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/12/2024) (0) |
| Feb 12, 2024 | N/A | Pro Hac Vice Attorney Bruce M. Wexler for Arbor Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/12/2024) (0) |
| Feb 12, 2024 | N/A | SO ORDERED re (24 in 1:23-cv-01080-MN, 21 in 1:23-cv-00833-MN) MOTION for Pro Hac Vice Appearance of Attorney Sarah E. Spencer filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 2/12/2024. (dlw) (Entered: 02/12/2024) (0) |
| Feb 12, 2024 | 25 | Pro Hac Vice Fee - Credit Card Payment received for Sarah E. Spencer. ( re 24 MOTION for Pro Hac Vice Appearance of Attorney Sarah E. Spencer )( Payment of $ 50, receipt number ADEDC-4335641).(Joyce, Alexandra) (Entered: 02/12/2024) (0) |
| Feb 12, 2024 | 24 | MOTION for Pro Hac Vice Appearance of Attorney Sarah E. Spencer - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc.. (Attachments: # 1 Certification for Sarah E. Spencer)(Joyce, Alexandra) (Entered: 02/12/2024) (0) |
| Feb 9, 2024 | N/A | Pro Hac Vice Attorney Zhiqiang Liu for Takeda Pharmaceutical Company Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/09/2024) (0) |
| Feb 7, 2024 | 23 | Pro Hac Vice Fee - Credit Card Payment received for Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno. ( re 11 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno )( Payment of $ 200, receipt number ADEDC-4332804).(Silver, Daniel) (Entered: 02/07/2024) (0) |
| Feb 5, 2024 | 22 | ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. A 5 day bench trial shall be set for 7/21/2025. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serve their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 2/5/2024. (dlw) (Entered: 02/05/2024) (0) |
| Jan 29, 2024 | N/A | Pro Hac Vice Attorney Elana B. Araj for Teva Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/29/2024) (0) |
| Jan 26, 2024 | N/A | SO ORDERED re 20 MOTION for Pro Hac Vice Appearance of Attorney Elana Araj filed by Teva Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 1/26/2024. (dlw) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 21 | Pro Hac Vice Fee - Credit Card Payment received for Elana Araj. ( re 20 MOTION for Pro Hac Vice Appearance of Attorney Elana Araj )( Payment of $ 50, receipt number ADEDC-4323755).(Hoeschen, Nathan) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 20 | MOTION for Pro Hac Vice Appearance of Attorney Elana Araj - filed by Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 01/26/2024) (3) |
| Jan 22, 2024 | N/A | SO ORDERED re 18 MOTION for Pro Hac Vice Appearance of Attorney Zhiqiang Liu filed by Takeda Pharmaceutical Company Limited. ORDERED by Judge Maryellen Noreika on 1/22/2024. (dlw) (Entered: 01/22/2024) (0) |
| Jan 18, 2024 | 19 | Pro Hac Vice Fee - Credit Card Payment received for Zhiqiang Liu. ( re 18 MOTION for Pro Hac Vice Appearance of Attorney Zhiqiang Liu )( Payment of $ 50, receipt number ADEDC-4317882).(Joyce, Alexandra) (Entered: 01/18/2024) (0) |
| Jan 18, 2024 | 18 | MOTION for Pro Hac Vice Appearance of Attorney Zhiqiang Liu - filed by Takeda Pharmaceutical Company Limited. (Attachments: # 1 Certification for Zhiqiang Liu)(Joyce, Alexandra) (Entered: 01/18/2024) (0) |
| Jan 3, 2024 | 17 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals, Inc. filed by Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 01/03/2024) (1) |
| Dec 28, 2023 | N/A | Pro Hac Vice Attorneys Danielle Z. Mills, Scott J. Bornstein, Jonathan D. Ball, Kathryn E. Albanese for Teva Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 12/28/2023) (0) |
| Dec 21, 2023 | N/A | SO ORDERED re 16 MOTION for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Jonathan D. Ball, Kathryn Albanese and Danielle Zapata Mills filed by Teva Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 12/21/2023. (dlw) (Entered: 12/21/2023) (0) |
| Dec 21, 2023 | 16 | MOTION for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Jonathan D. Ball, Kathryn Albanese and Danielle Zapata Mills - filed by Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 12/21/2023) (6) |
| Dec 13, 2023 | 15 | ANSWER to 14 Answer to Complaint,, Counterclaim, by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.(Silver, Daniel) (Entered: 12/13/2023) (7) |
| Nov 22, 2023 | 14 | ANSWER and Affirmative Defenses to 1 Complaint, COUNTERCLAIM against Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited by Teva Pharmaceuticals, Inc..(Keller, Karen) Modified on 11/27/2023 (mdb). (Entered: 11/22/2023) (25) |
| Nov 6, 2023 | 13 | SO ORDERED re 12 Stipulation Dismissing Teva Pharmaceutical Industries Ltd. Party Teva Pharmaceutical Industries Ltd. terminated. Signed by Judge Maryellen Noreika on 11/6/2023. (dlw) (Entered: 11/06/2023) (4) |
| Nov 3, 2023 | 12 | STIPULATION of Dismissal as to Teva Pharmaceutical Industries Ltd. by Teva Pharmaceuticals, Inc. (Keller, Karen) Modified on 11/6/2023 (dlw). (Entered: 11/03/2023) (4) |
| Oct 31, 2023 | N/A | SO ORDERED re (11 in 1:23-cv-01080-MN, 18 in 1:23-cv-00833-MN) MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 10/31/2023. (dlw) (Entered: 10/31/2023) (0) |
| Oct 30, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc.. (Attachments: # 1 Certifications for Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno)(Joyce, Alexandra) (Entered: 10/30/2023) (0) |
| Oct 12, 2023 | N/A | SO ORDERED re 10 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to November 22, 2023 (Set/Reset Answer Deadlines: Teva Pharmaceuticals, Inc. answer due 11/22/2023). ORDERED by Judge Maryellen Noreika on 10/12/2023. (dlw) (Entered: 10/12/2023) (0) |
| Oct 12, 2023 | 10 | STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to November 22, 2023 - filed by Teva Pharmaceuticals, Inc.. (Keller, Karen) (Entered: 10/12/2023) (1) |
| Oct 4, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 10/04/2023) (0) |
| Oct 2, 2023 | 9 | SUMMONS Returned Executed by Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.Teva Pharmaceuticals, Inc. served on 10/2/2023, answer due 10/23/2023. (Joyce, Alexandra) (Entered: 10/02/2023) (2) |
| Sep 29, 2023 | 8 | Summons Issued as to Teva Pharmaceuticals, Inc. on 9/29/2023. (twk) (Entered: 09/29/2023) (2) |
| Sep 29, 2023 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Master Trust Bank of Japan, Ltd. for Takeda Pharmaceutical Company Limited filed by Takeda Pharmaceutical Company Limited. (twk) (Entered: 09/29/2023) (2) |
| Sep 29, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Arbor Pharmaceuticals, Inc., Other Affiliate Azurity Pharmaceuticals, Inc. for Arbor Pharmaceuticals, LLC filed by Arbor Pharmaceuticals, LLC. (twk) (Entered: 09/29/2023) (2) |
| Sep 29, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc. (twk) (Entered: 09/29/2023) (2) |
| Sep 29, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,066,936; 9,169,238; 9,387,249. (twk) (Entered: 09/29/2023) (1) |
| Sep 29, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 17, 2023 (ANDA No. 218737). Date of Expiration of Patent: 9,066,936 (March 26, 2028); 9,169,238 (February 4, 2030); 9,387,249 (July 1, 2031). Thirty Month Stay Deadline: February 17, 2026 (ANDA No. 218737). (twk) (Entered: 09/29/2023) (2) |
| Sep 29, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 09/29/2023) (3) |
| Sep 29, 2023 | 1 | Complaint* (1) |
